{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for beta root_names_name in Any Name (approximate match)
Status:
Possibly Marketed Outside US
Source:
21 CFR 347
(2014)
Source URL:
First approved in 2014
Source:
21 CFR 347
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2013)
Source URL:
First approved in 2012
Source:
21 CFR 352
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
CLEAN ROUTINE by mybody
(2012)
Source URL:
First approved in 2012
Source:
OSSENTIAL DAILY POWER DEFENSE ANTI-AGING FORMULA by ZO Skin Health, Inc.
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Hydrocortisone Acetate, Iodoquinol by Bowyn Labs, LLC
(2011)
Source URL:
First approved in 2011
Source:
Hydrocortisone Acetate, Iodoquinol by Bowyn Labs, LLC
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M020
(2001)
Source URL:
First approved in 2001
Source:
M020
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 355
(2018)
Source URL:
First approved in 1993
Source:
21 CFR 352
Source URL:
Class:
POLYMER
Status:
First approved in 2019
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
INN:onzemipgene parvec [INN]
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
INN:arvenacogene sanparvovec [INN]
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
INN:pasemnogene gleparvovec [INN]
Source URL:
Class:
STRUCTURALLY DIVERSE
